Description of studies
First author, year [ref.] | Design | Subjects n | SDB definition with respect to predictor | SDB | Indices of SDB severity | Age years | Objective |
Anand, 2021 [16] | Prospective cross-sectional | 53 | OSA: AHI ≥1 events·h−1 | 96 | Mean±sd AHI 8.96±1.8 events·h−1 | Mean (range) 5.9 (3–11.8) | 1) Assess the effect of quality of sleep on development and behaviour of children with trisomy 21 2) Assess the effect of sleep apnoea on development and behaviour of children with trisomy 21 |
Austeng, 2014 [17] | Cross-sectional | 29 | OSA: OAI/AHI >1.5 events·h−1 | AHI >1.5 events·h−1 97% OAI >1.5 events·h−1 69% | Mean±sd AHI 10±8.8 events·h−1 | Mean 8 | 1) Measure prevalence and medical follow-up of OSA in young children with Down syndrome 2) Identify the association between OSA and age, BMI and airway surgery |
Banjar, 2013 [18] | Prospective cohort | 23 | OSA: AHI >1 events·h−1 | 82.6% | Mean AHI 12.3 events·h−1 Mean OAI 4.73 events·h−1 | Not reported | Identify sleep abnormalities in children with Down syndrome |
Basil, 2016 [19] | Retrospective cohort | 303 | OSAS: AHI ≥2 events·h−1 | 74% | Mild OSAS: 38.9% Moderate OSAS: 32.8% Severe OSAS: 28.2% | Mean±sd (range) 10.6±4.06 (2–18) | 1) Investigate whether children with Down syndrome are at increased risk of obesity 2) Explore OSAS, which is associated with obesity in children with Down syndrome |
Breslin, 2014 [20] | Prospective cohort | 38 | OSAS: AHI >1.5 events·h−1 | 61% | Mean±sd AHI 5.79±9.86 events·h−1 | Mean±sd (range) 9.6±.8 (7–12) | 1) Investigate the association between OSAS and cognition in children with Down syndrome 2) Investigate the effect of OSAS on sleep physiology in children with Down syndrome |
Brooks, 2015 [21] | Prospective cohort | 25 | OSA: AHI ≥5 events·h−1 | 40% | Mean±sd AHI 13.42±15.89 events·h−1 | Mean±sd (range) 10.14±3.39 (7.2–18.7) | 1) Investigate the effect of sleep and SDB on neuropsychological functioning of children with Down syndrome 2) Determine whether treatment of SDB improves cognitive functioning |
Chamseddin, 2019 [22] | Qualitative study with retrospective data collection | 106 | OSA: AHI ≥1 events·h−1 | 90% | Mean±sd AHI 16.7±6.25 events·h−1 | Mean±sd 7.3±4 | 1) To evaluate demographic, clinical and polysomnographic features of children with Down syndrome with clinical suspicion of OSA 2) Identify factors that predict OSA in children with Down syndrome |
Durhan, 2019 [23] | Cross-sectional | 18 | OSA: AHI ≥1 events·h−1 | 61.1% | Mean AHI 3.23 events·h−1 | Median (IQR) 6.6 (4.4–10.5) | Determine the effect of OSA on periodontal and dental health in children with Down syndrome |
Dyken, 2003 [9] | Prospective cohort | 19 | Sleep apnoea: apnoea index >1 event·h−1 and SaO2 low point <92% (with baseline SaO2 >92%) | 79% | Median (IQR) AHI 6.0 (3–8) events·h−1 Median (IQR) apnoea index 3.0 (2–5) events·h−1 | Mean±sd 9.1±4.7 | 1) Investigate OSA in young Down syndrome patients using PSG 2) Identify the effects of therapy on OSA in young Down syndrome patients |
Elsharkawi, 2017 [24] | Cross-sectional | 101 | OSA: AHI ≥1 events·h−1 | 42.6% | Mild OSA: 28% Moderate OSA: 2% Severe OSA: 13% | Mean±sd 9.1±4.0 | 1) Compare urinary biomarkers of children with Down syndrome to neurotypically healthy controls 2) Determine whether urinary biomarkers could predict a diagnosis of OSA |
Friedman, 2018 [25] | Cross-sectional | 113 | OSA: AHI ≥2 events·h−1 | Not reported | Mean AHI 13.76 events·h−1 | Mean 5.89 | 1) Assess parents' accuracy in reporting their children's breathing patterns 2) Assess risk factors associated with abnormal sleep study |
Jayaratne, 2017 [26] | Qualitative study with prospective data collection | 63 | OSA: AHI >1 events·h−1 | 44.2% | Not reported | Mean±sd (range) 7.49±4.86 (3.1–24.4) | 1) Characterise the facial morphology of children with Down syndrome 2) Compare facial anthropometric characteristics of Down syndrome patients with published norms 3) Compare facial anthropometric characteristics of Down syndrome patients with and without OSA to predict OSA status in patients with Down syndrome |
Lee, 2020 [27] | Cross-sectional | 30 | OSA: AHI ≥1 events·h−1 | 80% | Median (IQR) AHI 5.2 (1.7–15.7) events·h−1 | Median (IQR) 11.3 (9.4–15.6) | 1) Measure the prevalence of OSA in children with Down syndrome 2) Identify the role of OSA and sleep structure in affecting cognitive performance |
Maris, 2016 [28] | Cross-sectional | 54 | OSA: AHI![]() | 57.1% | Median (IQR) AHI 7.25 (5.7–9.8) events·h−1 | Median (range) 7.5 (4–18) | 1) Identify prevalence of sleep problems in children with Down syndrome as measured by Children's Sleep Habits Questionnaires 2) Compare prevalence of sleep problems in children with Down syndrome and controls 3) Investigate association between sleep problems and OSA |
Maris, 2016 [29] | Cross-sectional | 122 | OSA: AHI ![]() | 66.4% | Median (IQR) AHI 8.2 (4.3–16.7) events·h−1 | Median (IQR) 5.0 (2.8–10.5) | 1) Measure prevalence of OSA in children with Down syndrome 2) Identify factors that are associated with disease severity |
de Miguel-Díez, 2003 [4] | Prospective cohort | 108 | OSA: AHI ![]() | 54.6% | Mean±sd AHI 6.1±6.7 events·h−1 | Mean±sd (range) 7.9±4.5 (1–18) | 1) Measure the prevalence of SDB in children with Down syndrome 2) Identify factors that predispose children with Down syndrome to SDB |
Naime, 2021 [30] | Retrospective cohort | 158 | CSA: CAI >2 events·h−1 OSAS: AHI >2 events·h−1 | 79.1% OSAS 12% CSA | Median (IQR) CAI 0.20 (0.0–0.83) events·h−1 Median (IQR) AHI 5.95 (2.40–16.52) events·h−1 | Median (IQR) 4.8 (0.04–18.3) Median (IQR) 4.8 (2.31–9.02) | 1) Identify clinical predictors of central breathing problems in children with Down syndrome 2) The role of sex and OSA status on presence of central breathing problems |
Nehme, 2017 [8] | Retrospective cohort | 119 | OSA: AHI >5 events·h−1 Hypoventilation: carbon dioxide 50 mmHg for ≥25% of total sleep time | 42.9% | Median (IQR) AHI 3.6 (1.6–11.2) events·h−1 | Median (IQR) (range) 6.6 (4.4–10.5) (0.05–16.8) | Determine clinical predictors of SDB in children with Down syndrome |
Posada, 2019 [31] | Qualitative study with retrospective data collection | 53 | OSA: AHI >2 events·h−1 | 50.9% | Median (IQR) AHI: 0–23 months 7.0 (1.5–20.2) events·h−1 24–84 months 8.3 (1.9–30.0) events·h−1 85–156 months 8.4 (2.5–19.0) events·h−1 >156 months 13.0 (4.9–29.2) events·h−1 | Median (IQR) 3.4 (1.6–8.8) | Measure the incidence of sleep-related breathing disorders in children with Down syndrome living at high altitude |
Richard, 2020 [32] | Retrospective case–control study | 56 | Nocturnal hypoventilation: >25% of total sleep time spent with a PtcCO2 >50 mmHg | OSA 85.7% Nocturnal hypoventilation 17.9% | Median (IQR) AHI 5 (3–10.2) events·h−1 Median (IQR) mean PtcCO2 44 (43–46.5) mmHg | Median (IQR) 4.9 (2.0–7.8) | Compare PtcCO2 and pulse oximetry (SpO2) in children with Down syndrome and in control children with clinical signs of OSA |
Rosen, 2020 [33] | Qualitative study with retrospective data collection | 418 | OSA: AHI >1 events·h−1 | 42.1% | Mean AHI 3.6 events·h−1 Median AHI 0.6 events·h−1 | Mean (range) 7.27 (2–17) Median 6 | 1) Identify the prevalence of increased periodic limb movements of sleep in children with Down syndrome 2) Determine the correlation of periodic limb movements of sleep with OSA and levels of ferritin |
Shires, 2010 [34] | Retrospective cohort | 52 | OSA: AHI >1.0 events·h−1 | 63.5% | Mean AHI 18.7 events·h−1 | Mean±sd 9.3±4.5 | Identify the effect of body mass on the incidence of OSA in children with Down syndrome |
Skotko, 2017 [35] | Prospective cohort | 102 | OSA: AHI >1 events·h−1 | 44.1% | Not reported | Median (range) 5.6 (3–24.4) | To create a predictive model to help screen for OSA in children with Down syndrome |
Waters, 2020 [36] | Qualitative study with retrospective data collection | 152 | OSA: AHI >2 events·h−1 | 85.5% | Mean±sd AHI 13.1±22.4 events·h−1 | First PSG: mean±sd 5.0±4.3 Last PSG: mean±sd 8.2±5.1 | Identify the spectrum of OSA in children with Down syndrome |
SDB: sleep disordered breathing; OSA: obstructive sleep apnoea; AHI: apnoea–hypopnoea index; OAI: obstructive apnoea index; BMI: body mass index; OSAS: OSA syndrome; IQR: interquartile range; SaO2: arterial oxygen saturation; PSG: polysomnography; CSA: central sleep apnoea; CAI: central apnoea index; PtcCO2: transcutaneous partial pressure of carbon dioxide; SpO2: oxygen saturation measured by pulse oximetry.